Quent Capital’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-996
Closed -$101K 1567
2025
Q4
$101K Buy
996
+120
+14% +$9.64K 0.01% 551
2025
Q3
$47.9K Buy
+876
New +$43.8K ﹤0.01% 617
2025
Q2
Sell
-849
Closed -$36.8K 601
2025
Q1
$36.8K Hold
849
﹤0.01% 630
2024
Q4
$47.7K Buy
849
+1
+0.1% +$62 ﹤0.01% 591
2024
Q3
$57.8K Sell
848
-13
-2% -$734 0.01% 639
2024
Q2
$36.4K Hold
861
﹤0.01% 715
2024
Q1
$59.5K Buy
861
+13
+2% +$822 0.01% 622
2023
Q4
$62.7K Sell
848
-20
-2% -$1.31K 0.01% 565
2023
Q3
$59.2K Hold
868
0.01% 550
2023
Q2
$81.5K Hold
868
0.01% 472
2023
Q1
$58.9K Buy
868
+20
+2% +$1.29K 0.01% 552
2022
Q4
$42K Buy
848
+841
+12,014% +$34.4K 0.01% 624
2022
Q3
$0 Hold
7
﹤0.01% 1233
2022
Q2
$0 Hold
7
﹤0.01% 1212
2022
Q1
$0 Hold
7
﹤0.01% 1279
2021
Q4
$1K Buy
+7
New +$618 ﹤0.01% 1025

Other funds holding EXAS

Quent Capital's EXAS Position: Q1 2026 in Review

Quent Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 996 shares — an estimated $101K sold.

Quent Capital first reported a position in EXAS in Q4 2021 and held it in 16 quarters. The position peaked at $101K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Quent Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Quent Capital sold 996 Exact Sciences shares in Q1 2026, an estimated $101K.
  • Quent Capital first reported a position in Exact Sciences in Q4 2021 and held it in 16 quarters.
  • Quent Capital's Exact Sciences position peaked at $101K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.